Home » Topics » BioWorld Science

BioWorld Science
RSS

Supplemental NDA approved for Cipro

Aug. 22, 1997

Melatonin implant delays puberty in rats

Aug. 22, 1997

Apoptosis modulators reported in patent literature

Aug. 22, 1997

Alexion reports novel retroviral vectors for gene therapy

Aug. 22, 1997

Telomerase-inhibitory oligonucleotides for treating cancer

Aug. 22, 1997

Interneuron: Q3 1997 highlights

Aug. 22, 1997

Second gene discovered that delays AIDS

Aug. 22, 1997

Murex launches E. coli O157 assay

Aug. 22, 1997

Cerebrus develops novel animal satiety model

Aug. 22, 1997

HIV-O licensed to Abbott

Aug. 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...